ArthroCare Corp. says it has completed the acquisition of intriguingly named sinus surgery specialist, ENTrigue Surgical, Inc., in an all cash $45M transaction.
According to a press release, more than 30 million people in the United States are estimated to suffer from sinusitis, with approximately 500,000 patients treated surgically in the country each year.
ENTrigue Surgical designs and develops innovative implants, disposables and instruments for endoscopic sinus surgery including balloon dilation and will now operate within ArthroCare’s ENT product area as a complement to the ArthroCare Coblation® and Rapid Rhino® product lines currently being used by ENT surgeons worldwide.
In addition to the purchase consideration, previous shareholders of ENTrigue will also potentially benefit from a formula that sees additional payouts dependent on net sales increases during the next five years.
Source: ArthroCare Corporation